SE8903117D0 - MEDICINAL COMPREHENSIVE ANTAMANIDE - Google Patents

MEDICINAL COMPREHENSIVE ANTAMANIDE

Info

Publication number
SE8903117D0
SE8903117D0 SE8903117A SE8903117A SE8903117D0 SE 8903117 D0 SE8903117 D0 SE 8903117D0 SE 8903117 A SE8903117 A SE 8903117A SE 8903117 A SE8903117 A SE 8903117A SE 8903117 D0 SE8903117 D0 SE 8903117D0
Authority
SE
Sweden
Prior art keywords
antamanide
functional linear
disclosed
linear derivative
mammal
Prior art date
Application number
SE8903117A
Other languages
Swedish (sv)
Inventor
Z Wieczorek
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8903117A priority Critical patent/SE8903117D0/en
Publication of SE8903117D0 publication Critical patent/SE8903117D0/en
Priority to PCT/SE1990/000594 priority patent/WO1991004269A1/en
Priority to AU65141/90A priority patent/AU6514190A/en
Priority to EP90914794A priority patent/EP0493498A1/en
Priority to JP2513679A priority patent/JPH05500811A/en
Priority to CA002066721A priority patent/CA2066721A1/en
Priority to IE341690A priority patent/IE903416A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

Antamanide having cyclic formula (I), and/or a functional linear derivative thereof, for use as an immunosuppressive agent is disclosed. Furthermore, the use of Antamanide and/or a functional linear derivative thereof for the preparation of a medicament for immunosuppressive treatment, and a method of treating a mammal, including man, in need of immunosuppressive treatment comprising administering to said mammal a pharmacologically effective amount of Antamanide and/or a functional linear derivative thereof, are disclosed. Disclosed is also a pharmaceutical preparation comprising Antamanide and/or a functional linear derivative thereof, together with pharmaceutically acceptable carrier(s), excipient(s) and/or diluent(s).
SE8903117A 1989-09-22 1989-09-22 MEDICINAL COMPREHENSIVE ANTAMANIDE SE8903117D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8903117A SE8903117D0 (en) 1989-09-22 1989-09-22 MEDICINAL COMPREHENSIVE ANTAMANIDE
PCT/SE1990/000594 WO1991004269A1 (en) 1989-09-22 1990-09-17 Medicament comprising antamanide
AU65141/90A AU6514190A (en) 1989-09-22 1990-09-17 Medicament comprising antamanide
EP90914794A EP0493498A1 (en) 1989-09-22 1990-09-17 Medicament comprising antamanide
JP2513679A JPH05500811A (en) 1989-09-22 1990-09-17 Antamanid-containing drugs
CA002066721A CA2066721A1 (en) 1989-09-22 1990-09-17 Medicament comprising antamanide
IE341690A IE903416A1 (en) 1989-09-22 1990-09-21 Medicament comprising antamanide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903117A SE8903117D0 (en) 1989-09-22 1989-09-22 MEDICINAL COMPREHENSIVE ANTAMANIDE

Publications (1)

Publication Number Publication Date
SE8903117D0 true SE8903117D0 (en) 1989-09-22

Family

ID=20376948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903117A SE8903117D0 (en) 1989-09-22 1989-09-22 MEDICINAL COMPREHENSIVE ANTAMANIDE

Country Status (7)

Country Link
EP (1) EP0493498A1 (en)
JP (1) JPH05500811A (en)
AU (1) AU6514190A (en)
CA (1) CA2066721A1 (en)
IE (1) IE903416A1 (en)
SE (1) SE8903117D0 (en)
WO (1) WO1991004269A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505790A (en) * 1967-10-17 1971-04-15 Boehringer Sohn Ingelheim Process for the production of new cyclic decapeptides

Also Published As

Publication number Publication date
AU6514190A (en) 1991-04-18
CA2066721A1 (en) 1991-03-23
IE903416A1 (en) 1991-04-10
WO1991004269A1 (en) 1991-04-04
EP0493498A1 (en) 1992-07-08
JPH05500811A (en) 1993-02-18

Similar Documents

Publication Publication Date Title
DK77090A (en) Immunomodulatory AZASPIRANS
ATE113203T1 (en) PHARMACEUTICAL FORM FOR ADMINISTRATION OF AN ANTIPARKINSONIC AGENT.
KR930702022A (en) Treatment or prevention of type 1 diabetes by oral administration of insulin
MX171191B (en) PHARMACEUTICAL COMPOSITIONS OF GLIPIZIDE
MX9203543A (en) MEDICINE.
BR9306841A (en) Pharmaceutical composition process for providing an antihistamine treatment which does not induce any significant cardiac arrhythmia in a human patient and use of a composition for the manufacture of a medicine for use in an antihistamine treatment
DK1014996T3 (en) Preparations containing saccharide for the treatment of Alzheimer's disease and other amyloidoses
DE69230500D1 (en) Pharmaceutical dipeptide compositions and methods of use.
RU95105973A (en) Method of toxoplasmosis severity decrease, pharmaceutical composition, use of rifamycin derivatives for preparing the medicinal preparations for toxoplasmosis treatment
EP0484112A3 (en) Use of lithium in the treatment or prophylaxis of molluscum contagiosum
KR910005858A (en) Fatty acid therapy
SE8804640L (en) MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A
HK1041215A1 (en) Use of thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir in manufacturing pharmaceutical combination preparations for treating hepatitis b infection.
SE8903117D0 (en) MEDICINAL COMPREHENSIVE ANTAMANIDE
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
NO993921L (en) Medication for infertility and for increased fertility
KR870010871A (en) Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon
SE9003040D0 (en) ANALOGUES OF CYCLOLINOPEPTIDE AND THE USE THEREOF
ATE178800T1 (en) PHARMACEUTICAL PENTAPEPTIDE COMPOSITION AND USE THEREOF
NO961180L (en) Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease
ATE280584T1 (en) USE OF BETA INTERFERON TO PRODUCE A MEDICINAL PRODUCT FOR THE TREATMENT OF EWING'S SARCOMA AND EOE
DK493887A (en) BUCCAL FORMULATION